Female Stress Urinary Incontinence Treatment Devices Market - Key Research Findings
- Global female stress urinary incontinence treatment devices market size in 2018- ~US$ 530 Mn.
- The female stress urinary incontinence treatment devices market is expected to grow at a CAGR of ~7% over 2019-2029.
- North America and Europe are expected to remain the largest regional markets for female stress urinary incontinence treatment devices.
- High availability of female stress urinary incontinence treatment devices and the presence of a large number of manufacturers in these regions is expected to boost the demand for female stress urinary incontinence treatment devices in these regions.
- Various lawsuits filed against the mesh implants manufactured by various key players in the female stress urinary incontinence treatment devices market is expected to exploit the growth outlook of the female stress urinary incontinence treatment devices market
- For Instance, C. R. Bard, a company operating as a subsidiary of Boston Scientific Corporation, had ~1,098 pending pelvic mesh lawsuits in the federal court as of September 2019. The company has already made payments up to ~US$ 200 million for settlements of vaginal mesh implants of the Avaulta brand and other products.
Top Factors Shaping the Female Stress Urinary Incontinence Treatment Devices Market
- Wide acceptance of incontinence as a debilitating condition
- Rapid increase in awareness and acceptance for female stress urinary incontinence treatment devices across the world has played a major role in the growth of the female stress urinary incontinence treatment devices market over the past few years.
- Increasing government support to promote female stress urinary incontinence treatment devices among pregnant women
- As per the data provided by the Department of Obstetrics and Gynaecological Nursing, stress urinary incontinence in the female population base is considered to be the most common type of urinary incontinence among pregnant women, and is considered to have detrimental effects on the quality of the life of ~54.3 % of women
- Women in low-income regions are still unaware and uninformed about the treatment options available for stress urinary incontinence, however, increase in government support for awareness and research & development related to stress urinary incontinence in these regions is expected to boost the female stress urinary incontinence treatment devices market
Female Stress Urinary Incontinence Treatment Devices Market Structure Analysis
- The global female stress urinary incontinence treatment devices market is a fragmented market owing to the presence of a significant number of major market players and regional players.
- Some of the prominent companies in the female stress urinary incontinence treatment devices market include
- Boston Scientific Corporation
- Coloplast Corp.
- BD
- Ethicon U.S.
- LLC. (Johnson & Johnson Services Inc.)
- Cousin BiotechCaldera Medical.
- Manufacturers are focusing on receiving patent approval for the female stress urinary incontinence treatment devices offered by them, and major manufacturers are spending high amounts of capital for resolving the lawsuits filed against them for mesh implants.
- The Tier 1 companies are expected to contribute ~ 50%revenue share in the female stress urinary incontinence treatment devices market.
Key Segment
Based on the product type
- sling systems
- mid-urethral sling systems
- sub-urethral sling systems
- artificial urinary sphincter (AUS)
- injectable urethral bulking agents
Based on the End Use
- hospitals
- gynecology clinics
- homecare settings
Based on the Regions
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- Middle East & Africa (MEA).
Need specific information?
In the news
How Businesses Can Utilize Market Research to Create Reactive, Recession-proof Strategies for Survival
by - Sudip Saha, Managing Director and Co-Founder of Future Market Insights
Our Clients
View Our Reports from Healthcare
View Reports